Objective: To explore the seasonal correlation of the incidence of bronchial foreign body.
Method: Conduct retrospective analysis on clinical data of 1819 cases with bronchial foreign bodies in our hospital within an eight-year period (from January 2005 to January 2012), with cases classified into 12 groups by admission time (calculated by the Gregorian calendar in months, from January to December) and 4 groups by the Gregorian calendar in seasons (spring from March to May, summer from June to August, autumn from September to November, and winter from December to February), and observe whether the number of inpatients indicates any monthly or seasonal correlation.
Results: The months of November and December indicated the highest number of inpatients, with 263 cases and 274 cases, which accounted for 12.7% and 13.2% of all reported cases, respectively. On the other hand, June and July had the lowest number of inpatients, with 96 cases and 75 cases, which accounted for 4.6% and 3.6%, respectively. Based on season, 749 cases were admitted in autumn, accounting for 35.1%; 636 cases were admitted in winter, accounting for 29.8%; 474 cases were admitted in spring, accounting for 22.2%; and 275 cases were admitted in summer, accounting for 12.9%. The number of inpatients was periodic, with 12 months as a cycle, and significant difference (P<0.01) was determined by comparing the numbers of inpatients in winter and spring and those in summer and spring.
Conclusions: The number of child in patients with bronchial foreign bodies is monthly periodic, with 12 months as a cycle, and respectively reaching the peak in November and December, and the valley in June and July; the seasonal characteristic was apparently related to the monthly characteristic, with the numbers of inpatients in autumn and winter each year being significantly higher than in the spring and summer, and the incidence showing apparent seasonal correlation. The results allow for the proposal of relevant precautionary measures against bronchial foreign bodies in children.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.ijporl.2014.03.017 | DOI Listing |
JAMA Netw Open
January 2025
Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada.
Importance: Administrative health data serve as promising data sources to study transgender health at a population level in the absence of self-reported gender identity.
Objective: To develop and validate case definitions identifying transgender adults in administrative data compared with the reference standard of self-reported gender identity in a universal health care setting.
Design, Setting, And Participants: In this cohort study conducted in Alberta, Canada, data from provincial administrative health data sources including inpatient hospitalizations, emergency department encounters, primary care visits, prescription drug dispensations, and the provincial health insurance registry were linked and used to develop 15 case definitions (9 for transgender women and 6 for transgender men).
Sci Rep
January 2025
Department of Pharmacy, Shanghai Gonghui Hospital, Shanghai, People's Republic of China.
Elderly patients with multiple concomitant chronic diseases are the particularly vulnerable during the Coronavirus disease 2019 (COVID-19) epidemic, which accounts for a large number of COVID-19-related deaths. The purpose of the study was to investigate the impact of polypharmacy and potentially inappropriate medications (PIMs) on in-hospital mortality in a secondary hospital in China. A cross-sectional, retrospective study was conducted using electronic medical data collected from Shanghai Gonghui Hospital from April 2022 to June 2022.
View Article and Find Full Text PDFPediatrics
January 2025
Department of Pediatrics, Lucile Packard Children's Hospital, Palo Alto, California.
In response to a record number of immigrant families arriving in the United States through the southern border, a multidisciplinary team at a tertiary care children's hospital developed an inpatient asylum protocol (IAP) whose goals were to identify, screen, and support hospitalized asylum-seeking patients and their families. Identified patients were provided with specialized social work, case management, and legal support and were longitudinally followed after hospital discharge to ensure successful engagement with community resources. A total of 47 patients were enrolled over 2.
View Article and Find Full Text PDFJ Manag Care Spec Pharm
January 2025
The Comparative Health Outcomes, Policy, and Economics (CHOICE) Institute, Department of Pharmacy, University of Washington, Seattle.
Background: The introduction of cyclin-dependent kinases 4 and 6 inhibitors (CDK4/6is) has transformed the treatment landscape for patients with hormone receptor positive (HR+) and human epidermal growth factor receptor 2 negative (HER2-) metastatic breast cancer (MBC). To our knowledge, no studies have quantified health care resource utilization (HRU) or economic burden following CDK4/6i initiation in the Medicare population.
Objective: To describe HRU and quantify health care costs among Medicare-enrolled patients with HR+ HER2- MBC treated with CDK4/6is in the first-line setting.
Aust N Z J Obstet Gynaecol
January 2025
Obstetrics and Gynaecology, Mater Mothers Hospital, Brisbane, Queensland, Australia.
Background: Placenta praevia (PP) is a significant obstetric complication associated with antepartum haemorrhage (APH) and adverse maternal and fetal outcomes. Identifying risk factors for APH in women with PP is important for guiding management decisions.
Aims: This study aimed to identify risk factors associated with APH amongst women admitted to a single tertiary hospital with PP.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!